BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 3,600,000 shares, an increase of 21.2% from the March 15th total of 2,970,000 shares. Currently, 18.3% of the shares of the company are sold short. Based on an average trading […]